ResearchBib Share Your Research, Maximize Your Social Impacts
Sign for Notice Everyday Sign up >> Login

Genetic Polymorphisms and Cisplatin- Related Nephrotoxicity

Journal: Global Journal of Cancer Therapy (Vol.1, No. 1)

Publication Date:

Authors : ; ;

Page : 001-004

Keywords : Cisplatin; DNA repair enzymes; Metabolic enzymes; Nephrotoxicity; OCT; Polymorphisms;

Source : Downloadexternal Find it from : Google Scholarexternal

Abstract

Cis- diamminedichloroplatinum (cisplatin) is one of the most commonly used present day hemotherapeutic agents. It is used to treat a wide range of cancers including head and neck, lung, gastrointestinal tract, ovarian and genitourinary cancers. However, dose- limiting toxicity is often associated with cisplatin. It is known that cisplatin works more effectively with dose escalation, but significant risk for nephrotoxicity is often associated with higher doses [1].

Last modified: 2018-10-05 20:51:37